Calcitonin is a hormone that slows bone breakdown, and in osteoporosis management it now plays a limited, mostly short-term role. It can modestly reduce spine fracture risk and ease pain after an acute vertebral fracture, but it is weaker than modern drugs, does not clearly prevent hip fractures, and long-term use raised safety concerns. Today most specialists reserve it for short courses when other treatments are unsuitable.
This guide explains how calcitonin works, where it still fits, how it compares with other options, and what patients should ask their doctor.
What Is Calcitonin?
Calcitonin is a peptide hormone made by the parafollicular cells (C cells) of the thyroid gland. Its natural job is to help lower blood calcium when levels rise, acting as a counterweight to parathyroid hormone.
It does this mainly by inhibiting osteoclasts, the cells that dissolve old bone. Calcitonin binds to receptors on osteoclasts and quickly makes them less active, which reduces the release of calcium from the skeleton. The version used as a medicine is usually salmon calcitonin, which is more potent in humans than the human hormone.
Osteoporosis and Bone Remodeling
Osteoporosis is a condition of low bone mass and weakened bone structure that increases fracture risk. Bone is constantly remodeled: osteoclasts remove old bone and osteoblasts lay down new bone. When removal outpaces formation, bones thin and become fragile.
Common contributors include falling estrogen after menopause, aging, low calcium or vitamin D intake, inactivity, smoking, heavy alcohol use, and medicines such as long-term corticosteroids. Left untreated, the progression of osteoporosis is usually silent until a fracture occurs, most often in the spine, hip, or wrist.
How Osteoporosis Is Diagnosed
The standard test is dual-energy X-ray absorptiometry (DEXA), which measures bone mineral density and reports a T-score compared with a healthy young adult.
| T-score | Interpretation |
|---|---|
| -1.0 and above | Normal bone density |
| Between -1.0 and -2.5 | Osteopenia (low bone mass) |
| -2.5 or lower | Osteoporosis |
| -2.5 or lower plus a fragility fracture | Severe (established) osteoporosis |
A fragility fracture of the hip or spine can establish the diagnosis even without DEXA. In children and teenagers, doctors use age-matched Z-scores instead, as explained in our article on the diagnosis of osteoporosis in young people. Blood calcitonin levels are not used to diagnose osteoporosis.
How Calcitonin Works as a Treatment
As a drug, calcitonin reduces bone resorption by switching off osteoclasts. It has been given in two main forms:
- Nasal spray: historically a daily spray alternating nostrils.
- Injection: under the skin or into muscle, used mainly for Paget’s disease of bone and for high blood calcium.
Its antiresorptive effect on bone density is modest. It has shown a reduction in new vertebral fractures, but it has not convincingly reduced hip or other non-vertebral fractures, which are the most serious fractures in older adults.
Where Calcitonin Still Fits: Acute Fracture Pain
Calcitonin’s most useful remaining role is pain relief after an acute osteoporotic vertebral compression fracture. Patients often notice less back pain and can mobilize sooner when it is given for a few weeks after the fracture. The mechanism is not fully understood but may involve effects on pain pathways in the nervous system.
Because of safety concerns, this use is typically limited to a short course, often around 2 to 4 weeks, alongside other pain strategies. You can read about the wider range of options in our guide to osteoporosis pain treatment, and about night-time symptoms in our article on managing osteoporosis and hip pain at night.
Why Calcitonin Is No Longer First-Line
Several factors pushed calcitonin down the treatment list:
- Weaker fracture protection: other drugs reduce both spine and hip fractures more effectively.
- Cancer signal with long-term use: analyses of long-term studies found a small increase in cancer cases among calcitonin users. Regulators in Europe and the United States responded by restricting or advising against long-term use for osteoporosis.
- Tachyphylaxis: the effect on osteoclasts can wane with continued use.
How It Compares With Other Treatments
| Treatment | How it works | Hip fracture benefit | Typical role |
|---|---|---|---|
| Bisphosphonates (alendronate, risedronate, zoledronic acid) | Inhibit osteoclasts | Yes | First-line for most patients |
| Denosumab | Blocks RANKL, reducing osteoclast formation | Yes | First-line or when bisphosphonates unsuitable |
| Anabolic agents (teriparatide, abaloparatide, romosozumab) | Build new bone | Varies by agent | Very high fracture risk |
| Raloxifene | Estrogen-like effect on bone | No clear benefit | Selected postmenopausal women |
| Calcitonin | Inhibits osteoclasts | No clear benefit | Short-term pain after vertebral fracture |
Side Effects of Calcitonin
- Nasal irritation, dryness, crusting, or nosebleeds with the spray
- Nausea and flushing, more common with injections
- Injection-site redness
- Rare allergic reactions, since salmon calcitonin is a foreign protein
- Low blood calcium in susceptible patients
Supporting Bone Health Alongside Any Treatment
Medication works best with a solid foundation. Adequate calcium, mostly from food, and sufficient vitamin D are important, as discussed in our guide to supplements in osteoporosis management. Weight-bearing and balance exercise, stopping smoking, limiting alcohol, and making the home safer to prevent falls all reduce fracture risk.
Frequently Asked Questions
Is calcitonin still prescribed for osteoporosis?
Rarely as a long-term osteoporosis treatment. It is mainly used for short-term pain relief after a painful vertebral fracture, or occasionally when other drugs cannot be used. Availability of the nasal spray varies by country.
Does calcitonin increase bone density?
It produces a small increase in spinal bone density, much smaller than bisphosphonates, denosumab, or anabolic drugs. That is why it is not the preferred choice for long-term fracture prevention.
Is calcitonin safe to take?
Short courses are generally well tolerated, with nasal irritation and nausea the most common side effects. Long-term use has been restricted because of a small cancer signal, so doctors keep courses brief and weigh alternatives.
What should I use instead for long-term protection?
Most people with osteoporosis start with a bisphosphonate, while denosumab or bone-building drugs are options for others. Your doctor will choose based on your fracture risk, kidney function, and other health factors.
Key Takeaways
- Calcitonin is a thyroid hormone that inhibits osteoclasts and slows bone breakdown.
- It modestly reduces vertebral fractures but has no clear benefit for hip fractures.
- Its main modern use is short-term pain relief after an acute vertebral fracture.
- Long-term use is restricted due to a small cancer signal and weaker efficacy.
- Bisphosphonates, denosumab, and anabolic drugs are the mainstays of osteoporosis treatment.
For a complete overview of diagnosis, prevention, and treatment, visit our osteoporosis guide.
